Cannabis News
Can a CBD Vape Pen Help You Sleep Better?
Published
8 months agoon
By
admin
CBD vape pen does not cause sedation. Instead, it helps reduce anxiety, destress, reduce pain, improve mood, and thus help sleep. It may be better than using sedatives as it does not alter sleep quality or architecture.
Sleep disorders are very common and may increase the risk of a range of health conditions like obesity, diabetes, various mood disorders, including depression, and more. Poor sleep may also lower immunity and slow down regenerative processes.
There is a reason to consider CBD vape pens: they help you sleep better. Sedatives may help a person sleep quickly, but people often wake up with heavy-headedness or even headaches the next day. This is because sedatives alter brain function and sleep architecture. However, CBD vapes do not have those side effects; thus, it is a more natural way to enhance sleep.
How Does CBD Affect Sleep?
CBD interacts with the body’s endocannabinoid system (ECS), which plays a crucial role in regulating various physiological processes, including sleep. The ECS consists of cannabinoid receptors (CB1 and CB2) throughout the body. CBD may influence these receptors to promote balance and homeostasis, potentially improving sleep quality (1).
Research suggests that CBD may help alleviate factors that negatively impact sleep, such as anxiety, pain, and stress. By addressing these underlying issues, CBD can indirectly contribute to better sleep.
Potential Benefits of Using a CBD Vape Pen for Sleep
CBD vape pen is not as potent as sedatives, but it is safer. Additionally, CBD vape pens may be better than CBD oils or gummies in certain ways. Thus, many people find CBD vape ben as one of the better ways to enhance sleep quality. Some reasons to consider CBD vape pens are:
Faster Absorption and Quick Relief
One of the primary advantages of using a CBD vape pen is the speed at which CBD enters the bloodstream (2). Unlike oral consumption, which can take up to an hour or more to take effect, vaping allows CBD to be absorbed almost immediately. This quick action can be beneficial for individuals who have difficulty falling asleep due to anxiety or racing thoughts.
Anxiety and Stress Reduction
Anxiety and stress are common causes of sleep disturbances. CBD has been shown to have anxiolytic (anxiety-reducing) properties. It can help calm the mind and prepare the body for sleep. Using a CBD vape pen allows users to experience these calming effects quickly, making it easier to relax and fall asleep (3).
Pain Relief
Chronic pain can significantly disrupt sleep patterns. CBD is known for its analgesic (pain-relieving) properties, which can help alleviate pain and discomfort. Vaping CBD can provide rapid relief from pain, allowing individuals to settle into a more comfortable and restful state for sleep.
Improved Sleep Quality
Beyond helping individuals fall asleep, CBD may also improve overall sleep quality. Some studies suggest that CBD can influence sleep architecture, potentially increasing the amount of time spent in deep sleep stages. Deep sleep is essential for restorative rest and overall health.
Greater Benefit with Each Day
When using CBD for better sleep, it is essential to understand that some benefits are experienced from the very first hours of CBD vaping, but some benefits are experienced on consistent use.
When one uses a CBD vape pen, it almost immediately reduces stress and calms nerves. However, on consistent use, CBD accumulates a bit in a system. This means peak benefit from CBD vape pen use is experienced between days three and five.
Further, on continued CBD use through vaping or other means, some changes occur in the body. This includes altered stress response and specific changes in the brain structure. Such changes occur gradually over weeks. Hence, it is vital to keep using CBD to experience all its health effects.
Considerations for Using a CBD Vape Pen for Sleep
Although most CBD vape pens would help, it is vital to choose high-quality vape pens. Quite often, people choose products that are of poor quality, and then they wrongly conclude that CBD does not work for them. So, here are a few things to consider when using CBD vape pens for sleep:
Choosing the Right Product
When selecting a CBD vape pen, choosing a high-quality product from a reputable source is important. Look for vape pens that use pure CBD oil without harmful additives or contaminants. Third-party lab testing can provide assurance of the product’s quality and safety.
Dosage and Usage
Finding the right dosage of CBD can vary from person to person. It’s generally recommended to start with a low dose and gradually increase until the desired effects are achieved. For sleep, a lower dose might be sufficient, as higher doses of CBD can sometimes have a stimulating effect.
Timing of Use
To optimize the benefits of a CBD vape pen for sleep, timing is crucial. It’s typically best to use the vape pen 15 to 30 minutes before bedtime. This allows enough time for the calming effects of CBD to take hold, helping you relax and prepare for sleep.
Potential Side Effects
While CBD is generally well-tolerated, it’s important to be aware of potential side effects. Common side effects may include dry mouth, dizziness, and mild drowsiness. These effects are typically mild and temporary.
Legal Considerations
In the UK, CBD products must contain less than 0.2% THC to be legal. Ensure that the CBD vape pen and oil you purchase comply with local regulations to avoid any legal issues.
The Bottom Line
A CBD vape pen is an effective and fast way to improve sleep quality. However, do not forget to take other measures. So, improve your sleep routine, manage underlying causes, and make lifestyle changes. When CBD is combined with other lifestyle interventions, it can be of great help. Choosing high-quality products, starting with a low dose, and considering integrating other healthy sleep practices for the best results is crucial.
References
-
Kesner AJ, Lovinger DM. Cannabinoids, Endocannabinoids and Sleep. Front Mol Neurosci. 2020 Jul 22;13:125.
-
Millar SA, Stone NL, Yates AS, O’Sullivan SE. A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans. Front Pharmacol. 2018 Nov 26;9:1365.
-
Wright M, Di Ciano P, Brands B. Use of Cannabidiol for the Treatment of Anxiety: A Short Synthesis of Pre-Clinical and Clinical Evidence. Cannabis Cannabinoid Res. 2020 Sep 2;5(3):191–6.
MORE ON CBD FOR SLEEP, READ ON…
You may like
-
Our Awesome 11 Marijuana Strains To Celebrate Space Travel
-
All You Can Eat Buffets Are Back In A Big Way
-
DoorDash Launches Cannabis Home Delivery
-
11 Black Female-Owned Self-Care Cannabis Businesses to Support Right Now
-
Frosted Flakes Weed Strain Information & Review
-
7 mind-blowing, eye-opening road trip destinations for the cannabis enthusiast
Cannabis News
The Green Wave Crashes? – Has Cannabis Legalization Momentum Slowed Down around the World?
Published
2 days agoon
January 15, 2025By
admin
Has the Cannabis Legalization Momentum Slowed Down?
https://x.com/twinkdefcon/status/1865985135675359392
https://x.com/PLegalization/status/1867301591633760730
As a long-time observer of cannabis policy reform, I’ve watched with fascination as public attitudes towards marijuana have undergone a seismic shift since the turn of the millennium. The once-radical notion of legal cannabis has transformed into a mainstream policy position, supported by a growing majority of Americans across the political spectrum.
The real watershed moment came in 2012 when Colorado and Washington boldly stepped into uncharted territory, becoming the first states to legalize cannabis for adult recreational use. It was like watching the first dominos fall in what would become a cascade of reform. Since then, we’ve witnessed an almost clockwork-like progression of legalization, with new states joining the green wave year after year, whether through medical programs or full recreational legalization.
But something feels different lately. For the first time in recent memory, we’re seeing significant speedbumps in what seemed like an unstoppable movement. The November elections saw two cannabis measures fail at the ballot box – a surprising departure from the steady march of progress we’ve grown accustomed to. Scrolling through my X feed (formerly Twitter), I’ve noticed a shift in the conversation too. There’s a palpable sense of uncertainty in the air, and it’s got me thinking: Has the momentum of cannabis legalization finally begun to slow?
As someone who’s dedicated years to understanding and documenting this movement, I can’t help but wonder what’s behind this apparent deceleration. Is it just a temporary setback, or are we witnessing a more fundamental shift in the landscape of cannabis reform? In this article, we’ll dive deep into these questions and explore what’s really happening with the legalization movement in America.
Let’s unpack this together and see where the evidence leads us.
After decades of following cannabis reform, I’ve noticed a subtle but significant shift in the digital discourse lately. Some voices on X (formerly Twitter) have been particularly vocal about their concerns:
“Has anyone else noticed that Cannabis Legalization has slowed down significantly in recent months? I’m wondering if we’ll see federal legalization in our lifetime.” – @CannabisWatchdog
“The momentum of legalization is dwindling. Not sure if it’s because of the upcoming elections or if there’s something else at play…” – @GreenPolicy365
As I scroll through my feed, I can’t help but notice a change in the tenor of cannabis conversations. While polling consistently shows that a solid majority of Americans still support legalization, there’s been an uptick in negative sentiment that can’t be ignored. Perhaps most surprisingly, I’ve even seen calls for “re-illegalization” of cannabis – though this premise is fundamentally flawed since cannabis has never been fully legal at the federal level in the first place.
What’s particularly interesting is the emergence of vocal opposition groups who seem determined to fight against full legalization with everything they’ve got. The November election results, where we saw two cannabis measures fail, might be seen as evidence of their growing influence. Though, to be fair, these defeats could simply reflect the intense focus on the presidential race, with cannabis reform taking a back seat to what many viewed as more pressing political concerns.
Still, these failures caught many of us off guard. In the cannabis reform community, there was a prevailing sense that these measures were “sure things” – their defeat served as a wake-up call that we can’t take continued progress for granted.
Yet, let’s keep perspective here. While the negative voices might be getting louder, they’re not necessarily becoming more numerous. Support for legalization remains robust across demographic groups, and the cannabis industry has established itself as a significant economic force. The genie, as they say, is out of the bottle.
What we’re likely witnessing isn’t so much a reversal as a recalibration. The path to reform was never going to be entirely smooth or predictable. The next few years will be crucial in determining whether this is merely a temporary slowdown or a more substantial shift in public sentiment. Either way, those of us who’ve been in this space for years know that the only constant in cannabis policy is change.
Looking at the broader cultural landscape, I’m starting to notice some familiar patterns emerging in the cannabis reform movement. While I don’t foresee a complete reversal of the progress we’ve made, I do anticipate a temporary slowdown until we see decisive federal action – specifically, Congress finally addressing cannabis prohibition head-on.
In the meantime, we should brace ourselves for an uptick in anti-cannabis rhetoric. This isn’t just speculation – it’s based on a fundamental understanding of how societal attitudes tend to operate. Like a pendulum, when public opinion swings hard in one direction, there’s almost always an equal and opposite reaction coming.
We’ve seen this play out recently with the “woke” movement. After several years of progressive ideas dominating the cultural conversation, 2024 has marked a noticeable shift in the opposite direction. High-profile religious conversions, successful boycotts of brands deemed “too woke,” and increasingly vocal opposition to certain ideological positions all signal this pendulum swing in action.
Traditionally, drug policy reform has been associated with liberal politics – though it’s worth noting that Democrats, despite their rhetoric, haven’t actually done much to fundamentally change our drug laws. Now, as we appear to be entering a more conservative period, the cannabis movement needs to adapt its strategy accordingly. With conservatives likely to hold significant power over the next four years, we need to frame legalization in terms that resonate with right-leaning voters and politicians.
Yes, we’ll face more resistance in this environment. But I see this as an opportunity rather than a setback. The conservative principles of limited government, personal freedom, and states’ rights align perfectly with cannabis reform – we just need to make that case more effectively. After all, what’s more intrusive than the government telling adults what plants they can or cannot consume in their own homes?
The facts are on our side. The war on drugs has been an expensive, destructive failure – something that even many conservatives now acknowledge. Studies consistently show that youth cannabis use has actually decreased in states with legal markets. These are points that should appeal to pragmatic conservatives who value evidence-based policy making.
So while the pendulum swings right, it’s time for the cannabis reform movement to speak the language of conservatism: emphasis on personal responsibility, smart regulation that keeps products away from kids while supporting legitimate businesses, and policies that reduce crime by undermining the black market. If we can frame legalization in these terms, we might find unexpected allies on the right side of the aisle.
Let me be clear to all my fellow cannabis enthusiasts: there’s no need to panic. In states that have already embraced legal cannabis, those rights aren’t going anywhere. And for those still waiting for reform? It’s not a matter of if, but when. The train of legalization might be slowing down, but it hasn’t jumped the tracks.
What we’re witnessing is simply a shift in the cultural winds, and like any good navigator, we need to adjust our sails accordingly. The cannabis movement needs to evolve its messaging to resonate with the changing political landscape. We need to emphasize how legalization aligns with conservative values – fighting drug cartels, protecting our youth through regulated markets, generating substantial tax revenue, and creating legitimate American jobs.
These aren’t just talking points; they’re proven outcomes in states with legal markets. When we focus on these practical benefits rather than ideological arguments, we find common ground with conservatives who might otherwise be skeptical of legalization. After all, what’s more conservative than supporting small businesses, creating jobs, and reducing government waste on failed prohibition policies?
With conservative voices set to dominate the national conversation over the next four years, the cannabis industry needs to be strategic and pragmatic. We need to build bridges, not walls, and demonstrate how regulated cannabis markets can achieve conservative policy goals more effectively than prohibition ever could.
For now, we’ll watch and wait to see how these cultural shifts play out. But one thing’s for certain – the cannabis reform movement isn’t going anywhere. We’re just learning to speak a different dialect of the same language of freedom and common sense.
What do you think about the future of cannabis legalization? Drop a comment below and let me know your thoughts on navigating these changing times.
HOW TO SPOT THE BOTTOM IN THE CANNABIS MARKET, READ ON…
Cannabis News
Has the Marijuana Industry Hit Rock Bottom?
Published
3 days agoon
January 14, 2025By
admin
The cannabis industry has undergone a remarkable transformation over the past decade, evolving from a largely illicit market to a burgeoning sector with legal frameworks across numerous states and countries. However, this rapid growth has not come without its challenges. As the market matures, many marijuana businesses are facing financial distress due to various factors, including regulatory hurdles, market saturation, and changing consumer preferences. For savvy investors and entrepreneurs, these distressed businesses present unique opportunities for acquisition and growth. However, navigating this landscape requires caution and a comprehensive understanding of the risks involved.
The Current State of the Marijuana Industry
Market Growth and Challenges
The legal cannabis market in North America has seen exponential growth since the early 2010s. According to industry reports, the U.S. cannabis market was valued at approximately $13 billion in 2020 and is projected to reach $41 billion by 2025. This growth has been fueled by increasing legalization efforts at both state and federal levels, as well as a growing acceptance of cannabis for both medicinal and recreational use.
Despite this promising outlook, the industry faces significant challenges that have led to a wave of distressed businesses. These challenges include:
-
Regulatory Uncertainty: The patchwork of state laws creates confusion and compliance issues for businesses operating across state lines.
-
Market Saturation: In some regions, an influx of new licenses has led to oversupply, driving down prices and squeezing profit margins.
-
Banking Restrictions: Many cannabis businesses operate in cash due to federal banking restrictions, making it difficult to manage finances effectively.
-
High Operational Costs: From cultivation to distribution, the costs associated with running a cannabis business can be prohibitively high.
The Rise of Distressed Businesses
As these challenges mount, many marijuana businesses find themselves in precarious financial positions. Companies that once thrived may now be struggling to meet operational costs or repay debts. This creates a landscape ripe for investors looking for opportunities to acquire distressed assets at favorable prices.
Types of Distressed Businesses
Investors interested in the cannabis sector should be aware of the various types of distressed businesses available for acquisition:
1. Cultivation Facilities: These businesses may have excess inventory or face operational inefficiencies that hinder profitability.
2. Retail Dispensaries: With increased competition, some dispensaries may struggle to attract customers or maintain profitability.
3. Manufacturers: Companies producing cannabis-infused products may face challenges related to supply chain disruptions or regulatory compliance.
4. Ancillary Businesses: Companies providing services or products to the cannabis industry—such as packaging, security, or consulting—may also experience distress if their clients are struggling.
Evaluating Potential Acquisitions
When considering an investment in a distressed marijuana business, it is crucial to conduct thorough due diligence. Here are key factors to evaluate:
-
Balance Sheets: Review financial statements to assess assets, liabilities, and equity.
-
Cash Flow Analysis: Understand cash flow patterns to determine whether the business can sustain operations.
-
Debt Levels: Evaluate existing debt obligations and repayment schedules.
-
Management Team: Assess the experience and track record of the management team in navigating challenges within the cannabis sector.
-
Supply Chain Resilience: Investigate supply chain relationships and potential vulnerabilities.
-
Facility Conditions: Inspect physical locations for compliance with regulations and operational efficiency.
-
Licensing Status: Confirm that all necessary licenses are in place and up-to-date.
-
Legal Issues: Investigate any pending legal matters that could impact operations or financial stability.
-
Compliance History: Review past compliance issues with state regulations that could pose future risks.
Risks Involved
While there are substantial opportunities within distressed marijuana businesses, investors must also be aware of the risks involved:
The cannabis market is still relatively young and can be highly volatile. Prices for cannabis products can fluctuate dramatically based on supply and demand dynamics. Investors should be prepared for potential downturns that could affect profitability.
Changes in legislation can have immediate impacts on business operations. For instance, if a state decides to impose stricter regulations or taxes on cannabis sales, it could significantly affect profit margins.
Distressed businesses often have underlying operational issues that may not be immediately apparent. These could include outdated technology, ineffective marketing strategies, or poor customer service practices.
Investing in a distressed business can carry reputational risks if the company has been associated with legal troubles or poor business practices. It is essential to consider how these factors might affect your brand as an investor.
Strategies for Success
For those willing to navigate the complexities of investing in distressed marijuana businesses, several strategies can enhance the likelihood of success:
A well-defined business plan is essential for guiding operations post-acquisition. This plan should address:
-
Operational Improvements: Identify areas where efficiencies can be gained.
-
Market Positioning: Develop strategies for differentiating from competitors.
-
Financial Projections: Create realistic forecasts based on thorough market analysis.
Assembling an experienced management team with expertise in both cannabis operations and turnaround strategies is critical. This team should possess a deep understanding of regulatory requirements and market dynamics.
Given the regulatory complexities surrounding cannabis businesses, maintaining strict compliance is paramount. Establishing robust compliance protocols can help mitigate legal risks and foster positive relationships with regulators.
Leveraging insights from industry experts can provide valuable perspectives on market trends and operational best practices. Consider forming advisory boards or partnerships with experienced professionals in the cannabis sector.
Staying informed about emerging trends within the cannabis industry is essential for making strategic decisions. This includes keeping an eye on consumer preferences, technological advancements, and shifts in regulatory landscapes.
Case Studies of Successful Turnarounds
To illustrate how investors can successfully navigate distressed marijuana businesses, consider these case studies:
Case Study 1: GreenLeaf Cultivation Co.
GreenLeaf Cultivation Co., once a leading producer of organic cannabis products, faced significant financial difficulties due to oversupply in its region. After being acquired by a private equity firm specializing in distressed assets, GreenLeaf underwent a comprehensive restructuring process.
The new management team focused on streamlining operations by reducing overhead costs and optimizing cultivation techniques. They also rebranded the product line to appeal to health-conscious consumers. Within two years, GreenLeaf returned to profitability and expanded its market presence through strategic partnerships with local dispensaries.
Case Study 2: Urban Buds Dispensary
Urban Buds Dispensary struggled with declining sales amid increasing competition from new entrants in its market. After being acquired by an investor group with experience in retail turnaround strategies, Urban Buds implemented several key changes.
The new owners revamped the store layout to enhance customer experience and introduced loyalty programs to retain existing customers while attracting new ones. They also invested in targeted marketing campaigns highlighting unique product offerings. As a result, Urban Buds saw a 50% increase in sales within one year.
Conclusion
The landscape of distressed marijuana businesses presents both significant opportunities and formidable challenges for investors willing to engage with this complex sector. While potential returns can be substantial for those who navigate these waters wisely, it is crucial to approach such investments with caution. By conducting thorough due diligence, understanding market dynamics, focusing on compliance, and implementing effective turnaround strategies, investors can position themselves for success in this evolving industry. As the legal cannabis market continues to mature, those who are prepared will find that opportunities abound—but only for those who are willing to tread carefully through its intricacies.
WHERE IS THE BOTTOM IN THE CANNABIS INDUSTRY, READ ON…
Cannabis News
Global Cannabis Spotlight: The Czech Republic’s Psychomodulatory Substances Law
Published
3 days agoon
January 14, 2025By
admin
Last year, I attended an Expert Seminar in Amsterdam on Cannabis Regulation, EU Drug Law, Trade Rules, and the UN Drug Control Treaties. A central topic focused on advancing full cannabis legalization while complying with EU law and international Drug Treaties. During the discussion, Czechia presented its three-pillar approach to cannabis regulation: (1) decriminalization (in 2010, Czechia decriminalized cultivating up to five plants and possessing up to half an ounce of marijuana); (2) regulation of “psychomodulatory substances”; and (3) full commercial regulation. Like Germany, Malta, and Luxembourg, Czechia’s approach relies on scientific evidence. It shows that regulation, rather than prohibition, better protects children and society’s health, safety and welfare.
What is the Psychomodulatory Substances Law?
The law and related rules (effective on July 1, 2025), creates a new category of psychoactive substances with acceptable health risks. The current list includes four substances: low-THC cannabis extracts and tinctures (≤1% THC), kratom, and kratom extract. Other substances, like Hexahydrocannabinol (HHC), could be added if research shows their low health risks after two years. To be included, substances must prove they don’t pose significant public health or societal risks.
HHC faces hurdles in gaining approval. Czechia previously sought to ban HHC products in 2024. Additionally, the global community is still evaluating the substance. Last year, the WHO completed its review of HHC. Many expect the UN Commission on Narcotic Drugs to schedule it under the 1971 Convention. While cannabis is listed under the 1961 Single Convention, “industrial hemp” is excluded. This creates a legal loophole for low-THC hemp programs.
In Czechia, cannabis with less than 1% THC is classified as “technical hemp.” This classification has led to a legal grey area, increasing illicit-market activity. The Psychomodulatory Substances Law aims to curb illicit market influence by providing regulated access through licensed operators. This will help protect children, adolescents and adult consumers.
Once added to the list, psychomodulatory substances can be sold to adults (18+) for human consumption. Retail sales will begin in specialized stores by mid-2025. However, EU food and cosmetic laws prevent these substances from being sold in finished food products or cosmetics. Commercial operators will need permits to ensure compliance with regulations and local municipalities can impose their own usage restrictions.
Regulating instead of prohibiting ensures safer, quality-controlled products. This protects vulnerable groups. The law seeks to balance public health protections with Czechia’s obligations under international drug conventions and EU law. Czechia believes its approach aligns with its international commitments and the EU’s free movement of goods.
Legal regulation
Many hoped for full legalization of commercial cannabis. EU and international law create barriers the Czech government is unwilling to challenge. As more quasi-legal programs emerge across Europe, pressure may build on the EU to adjust its laws, allowing for fully regulated commercial cannabis sales. Until then, scaled-back approaches like Czechia’s psychomodulatory substances law will help fill the gap.
Conclusion
Czechia’s regulatory framework aims to reduce illicit market activity while prioritizing public health and welfare. It is not the first EU country to explore alternatives to full cannabis legalization and it likely won’t be the last. Despite a conservative government, Czechia balances traditional views with evidence that regulation, not prohibition, is the best approach. As seen in the U.S., low-THC legalization can create a robust market. It can also lead to unintended consequences, like unregulated intoxicating hemp products.
Since Czechia’s law does not allow ready-to-eat low-THC products, it remains unclear whether the country will face the same challenges seen elsewhere. While illicit market activity in cannabis extracts and tinctures will likely decrease, demand for ready-to-eat, low-THC products may rise. Until countries regulate the entire supply chain—from seed to sale (including ready-to-eat products and high-THC marijuana)—it will remain difficult to eliminate illicit market influence. Czechia operates within the constraints of EU and international law. This hinders EU members from implementing fully legalized commercial cannabis programs. As a result, the illicit market will continue to fill any gaps left by these limitations.
Our Awesome 11 Marijuana Strains To Celebrate Space Travel
All You Can Eat Buffets Are Back In A Big Way
DoorDash Launches Cannabis Home Delivery
11 Black Female-Owned Self-Care Cannabis Businesses to Support Right Now
Frosted Flakes Weed Strain Information & Review
7 mind-blowing, eye-opening road trip destinations for the cannabis enthusiast
Indiana Lawmakers File Bills To Legalize Marijuana And Fund Psilocybin Research In 2025
Discover Silly Nice’s 1G Bubble Hash and Other Top Cannabis Products at New York Dispensaries
Banking, veterans and research top priorities for Congress, new Cannabis Caucus chair says
63rd German Traffic Court Conference 2025: Cannabis in road traffic to take place Jan 30/31
Distressed Cannabis Business Takeaways – Canna Law Blog™
United States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)
What you Need to Know
Drug Testing for Marijuana – The Joint Blog
NCIA Write About Their Equity Scholarship Program
It has been a wild news week – here’s how CBD and weed can help you relax
Cannabis, alcohol firm SNDL loses CA$372.4 million in 2022
A new April 20 cannabis contest includes a $40,000 purse
Your Go-To Source for Cannabis Logos and Designs
UArizona launches online cannabis compliance online course
Trending
-
Cannabis News2 years ago
Distressed Cannabis Business Takeaways – Canna Law Blog™
-
One-Hit Wonders2 years ago
United States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)
-
Cannabis 1012 years ago
What you Need to Know
-
drug testing1 year ago
Drug Testing for Marijuana – The Joint Blog
-
Education2 years ago
NCIA Write About Their Equity Scholarship Program
-
Cannabis2 years ago
It has been a wild news week – here’s how CBD and weed can help you relax
-
Marijuana Business Daily2 years ago
Cannabis, alcohol firm SNDL loses CA$372.4 million in 2022
-
California2 years ago
A new April 20 cannabis contest includes a $40,000 purse